Hemophilia A Drug Market
1 Study Coverage
1.1 Hemophilia A Drug Product Introduction
1.2 Market by Type
1.2.1 Global Hemophilia A Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ATXF-8117
1.2.3 BAY-1093884
1.2.4 BIVV-001
1.2.5 BS-027125
1.2.6 Concizumab
1.2.7 CSL-689
1.2.8 Others
1.3 Market by Application
1.3.1 Global Hemophilia A Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hemophilia A Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Hemophilia A Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Hemophilia A Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hemophilia A Drug Sales by Region
2.4.1 Global Hemophilia A Drug Sales by Region (2017-2022)
2.4.2 Global Sales Hemophilia A Drug by Region (2023-2028)
2.5 Global Hemophilia A Drug Revenue by Region
2.5.1 Global Hemophilia A Drug Revenue by Region (2017-2022)
2.5.2 Global Hemophilia A Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hemophilia A Drug Sales by Manufacturers
3.1.1 Global Top Hemophilia A Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Hemophilia A Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hemophilia A Drug in 2021
3.2 Global Hemophilia A Drug Revenue by Manufacturers
3.2.1 Global Hemophilia A Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Hemophilia A Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hemophilia A Drug Revenue in 2021
3.3 Global Hemophilia A Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hemophilia A Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hemophilia A Drug Sales by Type
4.1.1 Global Hemophilia A Drug Historical Sales by Type (2017-2022)
4.1.2 Global Hemophilia A Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Hemophilia A Drug Sales Market Share by Type (2017-2028)
4.2 Global Hemophilia A Drug Revenue by Type
4.2.1 Global Hemophilia A Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Hemophilia A Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hemophilia A Drug Revenue Market Share by Type (2017-2028)
4.3 Global Hemophilia A Drug Price by Type
4.3.1 Global Hemophilia A Drug Price by Type (2017-2022)
4.3.2 Global Hemophilia A Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hemophilia A Drug Sales by Application
5.1.1 Global Hemophilia A Drug Historical Sales by Application (2017-2022)
5.1.2 Global Hemophilia A Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Hemophilia A Drug Sales Market Share by Application (2017-2028)
5.2 Global Hemophilia A Drug Revenue by Application
5.2.1 Global Hemophilia A Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Hemophilia A Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hemophilia A Drug Revenue Market Share by Application (2017-2028)
5.3 Global Hemophilia A Drug Price by Application
5.3.1 Global Hemophilia A Drug Price by Application (2017-2022)
5.3.2 Global Hemophilia A Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hemophilia A Drug Market Size by Type
6.1.1 North America Hemophilia A Drug Sales by Type (2017-2028)
6.1.2 North America Hemophilia A Drug Revenue by Type (2017-2028)
6.2 North America Hemophilia A Drug Market Size by Application
6.2.1 North America Hemophilia A Drug Sales by Application (2017-2028)
6.2.2 North America Hemophilia A Drug Revenue by Application (2017-2028)
6.3 North America Hemophilia A Drug Market Size by Country
6.3.1 North America Hemophilia A Drug Sales by Country (2017-2028)
6.3.2 North America Hemophilia A Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hemophilia A Drug Market Size by Type
7.1.1 Europe Hemophilia A Drug Sales by Type (2017-2028)
7.1.2 Europe Hemophilia A Drug Revenue by Type (2017-2028)
7.2 Europe Hemophilia A Drug Market Size by Application
7.2.1 Europe Hemophilia A Drug Sales by Application (2017-2028)
7.2.2 Europe Hemophilia A Drug Revenue by Application (2017-2028)
7.3 Europe Hemophilia A Drug Market Size by Country
7.3.1 Europe Hemophilia A Drug Sales by Country (2017-2028)
7.3.2 Europe Hemophilia A Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hemophilia A Drug Market Size by Type
8.1.1 Asia Pacific Hemophilia A Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Hemophilia A Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Hemophilia A Drug Market Size by Application
8.2.1 Asia Pacific Hemophilia A Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Hemophilia A Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Hemophilia A Drug Market Size by Region
8.3.1 Asia Pacific Hemophilia A Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Hemophilia A Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hemophilia A Drug Market Size by Type
9.1.1 Latin America Hemophilia A Drug Sales by Type (2017-2028)
9.1.2 Latin America Hemophilia A Drug Revenue by Type (2017-2028)
9.2 Latin America Hemophilia A Drug Market Size by Application
9.2.1 Latin America Hemophilia A Drug Sales by Application (2017-2028)
9.2.2 Latin America Hemophilia A Drug Revenue by Application (2017-2028)
9.3 Latin America Hemophilia A Drug Market Size by Country
9.3.1 Latin America Hemophilia A Drug Sales by Country (2017-2028)
9.3.2 Latin America Hemophilia A Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hemophilia A Drug Market Size by Type
10.1.1 Middle East and Africa Hemophilia A Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hemophilia A Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Hemophilia A Drug Market Size by Application
10.2.1 Middle East and Africa Hemophilia A Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hemophilia A Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Hemophilia A Drug Market Size by Country
10.3.1 Middle East and Africa Hemophilia A Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hemophilia A Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Overview
11.1.3 Bayer AG Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer AG Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer AG Recent Developments
11.2 BioMarin Pharmaceutical Inc
11.2.1 BioMarin Pharmaceutical Inc Corporation Information
11.2.2 BioMarin Pharmaceutical Inc Overview
11.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 BioMarin Pharmaceutical Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BioMarin Pharmaceutical Inc Recent Developments
11.3 Bioverativ Inc
11.3.1 Bioverativ Inc Corporation Information
11.3.2 Bioverativ Inc Overview
11.3.3 Bioverativ Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bioverativ Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bioverativ Inc Recent Developments
11.4 Catalyst Biosciences Inc
11.4.1 Catalyst Biosciences Inc Corporation Information
11.4.2 Catalyst Biosciences Inc Overview
11.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Catalyst Biosciences Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Catalyst Biosciences Inc Recent Developments
11.5 Chugai Pharmaceutical Co Ltd
11.5.1 Chugai Pharmaceutical Co Ltd Corporation Information
11.5.2 Chugai Pharmaceutical Co Ltd Overview
11.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chugai Pharmaceutical Co Ltd Recent Developments
11.6 CSL Ltd
11.6.1 CSL Ltd Corporation Information
11.6.2 CSL Ltd Overview
11.6.3 CSL Ltd Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CSL Ltd Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CSL Ltd Recent Developments
11.7 DBV Technologies SA
11.7.1 DBV Technologies SA Corporation Information
11.7.2 DBV Technologies SA Overview
11.7.3 DBV Technologies SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 DBV Technologies SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 DBV Technologies SA Recent Developments
11.8 Dimension Therapeutics Inc
11.8.1 Dimension Therapeutics Inc Corporation Information
11.8.2 Dimension Therapeutics Inc Overview
11.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dimension Therapeutics Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dimension Therapeutics Inc Recent Developments
11.9 EpiVax Inc
11.9.1 EpiVax Inc Corporation Information
11.9.2 EpiVax Inc Overview
11.9.3 EpiVax Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 EpiVax Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 EpiVax Inc Recent Developments
11.10 Expression Therapeutics LLC
11.10.1 Expression Therapeutics LLC Corporation Information
11.10.2 Expression Therapeutics LLC Overview
11.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Expression Therapeutics LLC Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Expression Therapeutics LLC Recent Developments
11.11 Green Cross Corp
11.11.1 Green Cross Corp Corporation Information
11.11.2 Green Cross Corp Overview
11.11.3 Green Cross Corp Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Green Cross Corp Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Green Cross Corp Recent Developments
11.12 Idogen AB
11.12.1 Idogen AB Corporation Information
11.12.2 Idogen AB Overview
11.12.3 Idogen AB Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Idogen AB Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Idogen AB Recent Developments
11.13 Immusoft Corp
11.13.1 Immusoft Corp Corporation Information
11.13.2 Immusoft Corp Overview
11.13.3 Immusoft Corp Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Immusoft Corp Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Immusoft Corp Recent Developments
11.14 LFB SA
11.14.1 LFB SA Corporation Information
11.14.2 LFB SA Overview
11.14.3 LFB SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 LFB SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 LFB SA Recent Developments
11.15 mAbxience SA
11.15.1 mAbxience SA Corporation Information
11.15.2 mAbxience SA Overview
11.15.3 mAbxience SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 mAbxience SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 mAbxience SA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hemophilia A Drug Industry Chain Analysis
12.2 Hemophilia A Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hemophilia A Drug Production Mode & Process
12.4 Hemophilia A Drug Sales and Marketing
12.4.1 Hemophilia A Drug Sales Channels
12.4.2 Hemophilia A Drug Distributors
12.5 Hemophilia A Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hemophilia A Drug Industry Trends
13.2 Hemophilia A Drug Market Drivers
13.3 Hemophilia A Drug Market Challenges
13.4 Hemophilia A Drug Market Restraints
14 Key Findings in The Global Hemophilia A Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Hemophilia A Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of ATXF-8117
Table 3. Major Manufacturers of BAY-1093884
Table 4. Major Manufacturers of BIVV-001
Table 5. Major Manufacturers of BS-027125
Table 6. Major Manufacturers of Concizumab
Table 7. Major Manufacturers of CSL-689
Table 8. Major Manufacturers of Others
Table 9. Global Hemophilia A Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Hemophilia A Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Hemophilia A Drug Sales by Region (2017-2022) & (K Pcs)
Table 12. Global Hemophilia A Drug Sales Market Share by Region (2017-2022)
Table 13. Global Hemophilia A Drug Sales by Region (2023-2028) & (K Pcs)
Table 14. Global Hemophilia A Drug Sales Market Share by Region (2023-2028)
Table 15. Global Hemophilia A Drug Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Hemophilia A Drug Revenue Market Share by Region (2017-2022)
Table 17. Global Hemophilia A Drug Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Hemophilia A Drug Revenue Market Share by Region (2023-2028)
Table 19. Global Hemophilia A Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 20. Global Hemophilia A Drug Sales Share by Manufacturers (2017-2022)
Table 21. Global Hemophilia A Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Hemophilia A Drug Revenue Share by Manufacturers (2017-2022)
Table 23. Hemophilia A Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 24. Global Hemophilia A Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Hemophilia A Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia A Drug as of 2021)
Table 26. Hemophilia A Drug Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Hemophilia A Drug Product Offered
Table 28. Date of Manufacturers Enter into Hemophilia A Drug Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 31. Global Hemophilia A Drug Sales by Type (2023-2028) & (K Pcs)
Table 32. Global Hemophilia A Drug Sales Share by Type (2017-2022)
Table 33. Global Hemophilia A Drug Sales Share by Type (2023-2028)
Table 34. Global Hemophilia A Drug Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Hemophilia A Drug Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Hemophilia A Drug Revenue Share by Type (2017-2022)
Table 37. Global Hemophilia A Drug Revenue Share by Type (2023-2028)
Table 38. Hemophilia A Drug Price by Type (2017-2022) & (USD/Pcs)
Table 39. Global Hemophilia A Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 40. Global Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 41. Global Hemophilia A Drug Sales by Application (2023-2028) & (K Pcs)
Table 42. Global Hemophilia A Drug Sales Share by Application (2017-2022)
Table 43. Global Hemophilia A Drug Sales Share by Application (2023-2028)
Table 44. Global Hemophilia A Drug Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Hemophilia A Drug Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Hemophilia A Drug Revenue Share by Application (2017-2022)
Table 47. Global Hemophilia A Drug Revenue Share by Application (2023-2028)
Table 48. Hemophilia A Drug Price by Application (2017-2022) & (USD/Pcs)
Table 49. Global Hemophilia A Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 50. North America Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 51. North America Hemophilia A Drug Sales by Type (2023-2028) & (K Pcs)
Table 52. North America Hemophilia A Drug Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Hemophilia A Drug Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 55. North America Hemophilia A Drug Sales by Application (2023-2028) & (K Pcs)
Table 56. North America Hemophilia A Drug Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Hemophilia A Drug Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)
Table 59. North America Hemophilia A Drug Sales by Country (2023-2028) & (K Pcs)
Table 60. North America Hemophilia A Drug Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Hemophilia A Drug Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 63. Europe Hemophilia A Drug Sales by Type (2023-2028) & (K Pcs)
Table 64. Europe Hemophilia A Drug Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Hemophilia A Drug Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 67. Europe Hemophilia A Drug Sales by Application (2023-2028) & (K Pcs)
Table 68. Europe Hemophilia A Drug Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Hemophilia A Drug Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)
Table 71. Europe Hemophilia A Drug Sales by Country (2023-2028) & (K Pcs)
Table 72. Europe Hemophilia A Drug Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Hemophilia A Drug Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 75. Asia Pacific Hemophilia A Drug Sales by Type (2023-2028) & (K Pcs)
Table 76. Asia Pacific Hemophilia A Drug Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Hemophilia A Drug Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 79. Asia Pacific Hemophilia A Drug Sales by Application (2023-2028) & (K Pcs)
Table 80. Asia Pacific Hemophilia A Drug Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Hemophilia A Drug Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Hemophilia A Drug Sales by Region (2017-2022) & (K Pcs)
Table 83. Asia Pacific Hemophilia A Drug Sales by Region (2023-2028) & (K Pcs)
Table 84. Asia Pacific Hemophilia A Drug Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Hemophilia A Drug Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 87. Latin America Hemophilia A Drug Sales by Type (2023-2028) & (K Pcs)
Table 88. Latin America Hemophilia A Drug Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Hemophilia A Drug Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 91. Latin America Hemophilia A Drug Sales by Application (2023-2028) & (K Pcs)
Table 92. Latin America Hemophilia A Drug Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Hemophilia A Drug Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)
Table 95. Latin America Hemophilia A Drug Sales by Country (2023-2028) & (K Pcs)
Table 96. Latin America Hemophilia A Drug Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Hemophilia A Drug Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Hemophilia A Drug Sales by Type (2017-2022) & (K Pcs)
Table 99. Middle East and Africa Hemophilia A Drug Sales by Type (2023-2028) & (K Pcs)
Table 100. Middle East and Africa Hemophilia A Drug Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Hemophilia A Drug Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Hemophilia A Drug Sales by Application (2017-2022) & (K Pcs)
Table 103. Middle East and Africa Hemophilia A Drug Sales by Application (2023-2028) & (K Pcs)
Table 104. Middle East and Africa Hemophilia A Drug Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Hemophilia A Drug Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Hemophilia A Drug Sales by Country (2017-2022) & (K Pcs)
Table 107. Middle East and Africa Hemophilia A Drug Sales by Country (2023-2028) & (K Pcs)
Table 108. Middle East and Africa Hemophilia A Drug Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Hemophilia A Drug Revenue by Country (2023-2028) & (US$ Million)
Table 110. Bayer AG Corporation Information
Table 111. Bayer AG Description and Major Businesses
Table 112. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 113. Bayer AG Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer AG Recent Developments
Table 115. BioMarin Pharmaceutical Inc Corporation Information
Table 116. BioMarin Pharmaceutical Inc Description and Major Businesses
Table 117. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 118. BioMarin Pharmaceutical Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. BioMarin Pharmaceutical Inc Recent Developments
Table 120. Bioverativ Inc Corporation Information
Table 121. Bioverativ Inc Description and Major Businesses
Table 122. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 123. Bioverativ Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bioverativ Inc Recent Developments
Table 125. Catalyst Biosciences Inc Corporation Information
Table 126. Catalyst Biosciences Inc Description and Major Businesses
Table 127. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 128. Catalyst Biosciences Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Catalyst Biosciences Inc Recent Developments
Table 130. Chugai Pharmaceutical Co Ltd Corporation Information
Table 131. Chugai Pharmaceutical Co Ltd Description and Major Businesses
Table 132. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Chugai Pharmaceutical Co Ltd Recent Developments
Table 135. CSL Ltd Corporation Information
Table 136. CSL Ltd Description and Major Businesses
Table 137. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 138. CSL Ltd Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. CSL Ltd Recent Developments
Table 140. DBV Technologies SA Corporation Information
Table 141. DBV Technologies SA Description and Major Businesses
Table 142. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 143. DBV Technologies SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. DBV Technologies SA Recent Developments
Table 145. Dimension Therapeutics Inc Corporation Information
Table 146. Dimension Therapeutics Inc Description and Major Businesses
Table 147. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 148. Dimension Therapeutics Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Dimension Therapeutics Inc Recent Developments
Table 150. EpiVax Inc Corporation Information
Table 151. EpiVax Inc Description and Major Businesses
Table 152. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 153. EpiVax Inc Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. EpiVax Inc Recent Developments
Table 155. Expression Therapeutics LLC Corporation Information
Table 156. Expression Therapeutics LLC Description and Major Businesses
Table 157. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 158. Expression Therapeutics LLC Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Expression Therapeutics LLC Recent Developments
Table 160. Green Cross Corp Corporation Information
Table 161. Green Cross Corp Description and Major Businesses
Table 162. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 163. Green Cross Corp Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Green Cross Corp Recent Developments
Table 165. Idogen AB Corporation Information
Table 166. Idogen AB Description and Major Businesses
Table 167. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 168. Idogen AB Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Idogen AB Recent Developments
Table 170. Immusoft Corp Corporation Information
Table 171. Immusoft Corp Description and Major Businesses
Table 172. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 173. Immusoft Corp Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Immusoft Corp Recent Developments
Table 175. LFB SA Corporation Information
Table 176. LFB SA Description and Major Businesses
Table 177. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 178. LFB SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. LFB SA Recent Developments
Table 180. mAbxience SA Corporation Information
Table 181. mAbxience SA Description and Major Businesses
Table 182. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 183. mAbxience SA Hemophilia A Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. mAbxience SA Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Hemophilia A Drug Distributors List
Table 188. Hemophilia A Drug Customers List
Table 189. Hemophilia A Drug Market Trends
Table 190. Hemophilia A Drug Market Drivers
Table 191. Hemophilia A Drug Market Challenges
Table 192. Hemophilia A Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia A Drug Product Picture
Figure 3. Global Hemophilia A Drug Market Share by Type in 2021 & 2028
Figure 3. ATXF-8117 Product Picture
Figure 4. BAY-1093884 Product Picture
Figure 5. BIVV-001 Product Picture
Figure 6. BS-027125 Product Picture
Figure 7. Concizumab Product Picture
Figure 8. CSL-689 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Hemophilia A Drug Market Share by Application in 2021 & 2028
Figure 11. Clinic
Figure 12. Hospital
Figure 13. ASCs
Figure 14. Hemophilia A Drug Report Years Considered
Figure 15. Global Hemophilia A Drug Sales 2017-2028 (K Pcs)
Figure 16. Global Hemophilia A Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Hemophilia A Drug Revenue 2017-2028 (US$ Million)
Figure 18. Global Hemophilia A Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Hemophilia A Drug Sales Market Share by Region (2017-2022)
Figure 20. Global Hemophilia A Drug Sales Market Share by Region (2023-2028)
Figure 21. North America Hemophilia A Drug Sales YoY (2017-2028) & (K Pcs)
Figure 22. North America Hemophilia A Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Hemophilia A Drug Sales YoY (2017-2028) & (K Pcs)
Figure 24. Europe Hemophilia A Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Hemophilia A Drug Sales YoY (2017-2028) & (K Pcs)
Figure 26. Asia-Pacific Hemophilia A Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Hemophilia A Drug Sales YoY (2017-2028) & (K Pcs)
Figure 28. Latin America Hemophilia A Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Hemophilia A Drug Sales YoY (2017-2028) & (K Pcs)
Figure 30. Middle East & Africa Hemophilia A Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Hemophilia A Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Hemophilia A Drug in the World: Market Share by Hemophilia A Drug Revenue in 2021
Figure 33. Global Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Hemophilia A Drug Sales Market Share by Type (2017-2028)
Figure 35. Global Hemophilia A Drug Revenue Market Share by Type (2017-2028)
Figure 36. Global Hemophilia A Drug Sales Market Share by Application (2017-2028)
Figure 37. Global Hemophilia A Drug Revenue Market Share by Application (2017-2028)
Figure 38. North America Hemophilia A Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Hemophilia A Drug Revenue Market Share by Type (2017-2028)
Figure 40. North America Hemophilia A Drug Sales Market Share by Application (2017-2028)
Figure 41. North America Hemophilia A Drug Revenue Market Share by Application (2017-2028)
Figure 42. North America Hemophilia A Drug Sales Share by Country (2017-2028)
Figure 43. North America Hemophilia A Drug Revenue Share by Country (2017-2028)
Figure 44. U.S. Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Hemophilia A Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe Hemophilia A Drug Revenue Market Share by Type (2017-2028)
Figure 48. Europe Hemophilia A Drug Sales Market Share by Application (2017-2028)
Figure 49. Europe Hemophilia A Drug Revenue Market Share by Application (2017-2028)
Figure 50. Europe Hemophilia A Drug Sales Share by Country (2017-2028)
Figure 51. Europe Hemophilia A Drug Revenue Share by Country (2017-2028)
Figure 52. Germany Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 53. France Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Hemophilia A Drug Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Hemophilia A Drug Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Hemophilia A Drug Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Hemophilia A Drug Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Hemophilia A Drug Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Hemophilia A Drug Revenue Share by Region (2017-2028)
Figure 63. China Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 66. India Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Hemophilia A Drug Sales Market Share by Type (2017-2028)
Figure 74. Latin America Hemophilia A Drug Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Hemophilia A Drug Sales Market Share by Application (2017-2028)
Figure 76. Latin America Hemophilia A Drug Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Hemophilia A Drug Sales Share by Country (2017-2028)
Figure 78. Latin America Hemophilia A Drug Revenue Share by Country (2017-2028)
Figure 79. Mexico Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Hemophilia A Drug Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Hemophilia A Drug Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Hemophilia A Drug Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Hemophilia A Drug Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Hemophilia A Drug Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Hemophilia A Drug Revenue Share by Country (2017-2028)
Figure 88. Turkey Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Hemophilia A Drug Revenue (2017-2028) & (US$ Million)
Figure 91. Hemophilia A Drug Value Chain
Figure 92. Hemophilia A Drug Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
Industry Market Size
